[Screening for ovarian cancers: critical analysis]
- PMID: 7951617
[Screening for ovarian cancers: critical analysis]
Abstract
The ovarian cancers have a low incidence rate and a high mortality rate mainly due to a late diagnosis. The potential value of ultrasonography and measurements of tumour associated markers to detect early ovarian cancer suggest the interest of a screening strategy. The analysis of the conditions for efficacy of a such screening program, of the predictive values of ultrasonography and tumour associated markers measurements and of the results of preliminary studies does not confirm on a rational basis the potential interest of screening strategies.
Similar articles
-
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):306-18. doi: 10.1158/1055-9965.EPI-04-0423. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734951
-
Personalizing ovarian cancer screening.J Natl Cancer Inst. 2010 Aug 4;102(15):1112-3. doi: 10.1093/jnci/djq296. Epub 2010 Jul 28. J Natl Cancer Inst. 2010. PMID: 20668268 No abstract available.
-
Listen for the "whispering disease". Learn the subtle signs and symptoms of ovarian cancer.Nurs Manage. 2000 Apr;31(4):30-1. Nurs Manage. 2000. PMID: 15127636 No abstract available.
-
Genetic, biochemical, and multimodal approaches to screening for ovarian cancer.Gynecol Oncol. 1994 Dec;55(3 Pt 2):S22-7. doi: 10.1006/gyno.1994.1336. Gynecol Oncol. 1994. PMID: 7835805 Review. No abstract available.
-
Circulating tumour markers in ovarian tumours.Forum (Genova). 2000 Oct-Dec;10(4):383-92. Forum (Genova). 2000. PMID: 11535987 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical